Flagship explainer
How RHYTHM PHARMACEUTICALS, INC. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $190M | 100% |
| |
| Cost of revenue | $19.5M | 10% |
|
| $170M | 90% |
| |
| −$192M | −101% |
| |
| Income before tax | −$196M | −103% |
|
| Income tax | $497000 | 0% |
|
| −$197M | −104% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001628280-26-012399